![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 16257-16264, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The prokaryotic
New Insights into Host Factor Requirements for Prokaryotic
-Recombinase-mediated Reactions in Mammalian Cells*
,
,
,
,
,
¶
Departamento de Inmunología y
Oncología and § Biotecnología Microbiana,
Centro Nacional de Biotecnología, CSIC, Campus Universidad
Autónoma de Madrid, Cantoblanco, E-28049 Madrid, Spain
-recombinase catalyzes
site-specific recombination between two directly oriented minimal
six sites in mammalian cells, both on episomic and
chromatin-integrated substrates. Using a specific recombination
activated gene expression system, we report the site-specific
recombination activity of an enhanced green fluorescent protein
(EGFP) fused version of
-recombinase (
-EGFP). This allows
expression of active
-recombinase detectable in vivo and
in fixed cells by fluorescence microscopy. In addition, cellular
viability is compatible with a substantial level of expression of the
-EGFP protein. Using fluorescence-activated cell sorting, we have
been able to enrich cell populations expressing this fusion protein.
Application of this strategy has allowed us to study in more depth the
host factor requirements for this system. Previous work showed that
eukaryotic HMG1 protein was necessary and sufficient to help
-recombinase activity in vitro. The influence of ectopic expression of HMG1 protein in the recombination process has been analyzed, indicating that HMG1 overexpression does not lead to a
significant increase on the efficiency of
-recombinase-mediated recombination both on episomal substrates and chromatin-associated targets. In addition,
-recombinase-mediated recombination has been
demonstrated in HMG1 deficient cells at the same levels as in wild type
cells. These data demonstrate the existence of cellular factors
different from HMG-1 that can act as helpers for
-recombinase activity in the eukaryotic environment.
*
This work was partially supported by Grants 07/057/96 and
08.6/0021/1997 from the Consejería de Cultura de la Comunidad
Autónoma de Madrid, Grant SAF98-0008-CO4-O3 del Plan Nacional de
Salud y Farmacia, Comisión Interministerial de Ciencia y
Tecnología, and Grant BIO4-CT95-0274 from the
Biotechnology Program, EU (to A. B.), and Grant PB96-0817 from
Dirección General de Investigación, Ciencia y
Tecnología, Grants 2FD97-1692-C02-02 and 08.3/0028/98 from Consejería de Cultura de la Comunidad Autónoma de
Madrid (to J. C. A.). The Department of Immunology and
Oncology was founded and is supported by the Spanish Research Council
(Consejo Superior de Investigaciones Científicas) and
the Pharmacia Corporation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
P. Servert, J. Garcia-Castro, V. Diaz, D. Lucas, M. A. Gonzalez, C. Martinez-A, and A. Bernad Inducible model for {beta}-six-mediated site-specific recombination in mammalian cells Nucleic Acids Res., January 3, 2006; 34(1): e1 - e1. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |